News
The U.S. Food and Drug Administration has declined to approve Ultragenyx Pharmaceutical's experimental gene therapy to treat ...
The U.S. Food and Drug Administration has approved Bravecto Quantum, a new shot that protects dogs six months or older ...
Class II recalls from the FDA indicate a potential risk to consumer safety where use or exposure to the product may cause ...
Presented by Express Scripts Pharmacy Benefit Services{beacon} Health Care Health Care The Big Story Senate panel clears ...
Emergency personnel found the 43-year-old physical therapist dead inside the chamber at his Arizona health clinic, which ...
22h
News Nation on MSNFDA Commissioner: ‘We want to focus on food’“We want to focus on food. People forget that the ‘F’ in FDA stands for food,” Makary said. Makary noted that the processed ...
Opinion
18hon MSNOpinion
The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and unnecessary delays in the regulatory process.
18h
Daily Voice on MSNDeadly Defect In Infant Breathing Systems Prompts Urgent Recall, FDA SaysA major infant ventilator component has been recalled because it could come apart during use, potentially causing organ ...
A long-acting flea and tick treatment from Merck Animal Health has earned approval for dogs at least six months old from the Food and Drug Administration (FDA).
The Food and Drug Administration has approved a first of its kind, once-yearly shot designed to protect dogs from fleas and ...
Novartis cannot block drugmaker MSN Pharmaceuticals from launching a generic version of its blockbuster heart-failure drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results